U.S. flag

An official website of the United States government

Filters

See more specimen types...
See more states

Other countries

See more countries

Results: 1 to 20 of 58

Tests names and labsConditionsGenes, analytes, and microbesMethods

TSPAN12 Gene Exudative vitreoretinopathy type 5 NGS Genetic DNA Test

DNA Labs India
India
11
  • S Mutation scanning of the entire coding region

MVL Vision Panel

Molecular Vision Laboratory
United States
13581028
  • C Sequence analysis of the entire coding region

TSPAN12 - NGS including CNV analysis

Centogene AG - the Rare Disease Company
Germany
11
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CentoVision Panel

Centogene AG - the Rare Disease Company
Germany
417413
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Early-Onset High Myopia Panel

PreventionGenetics, part of Exact Sciences
United States
285137
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Exudative vitreoretinopathy Comprehensive panel

HNL Genomics Connective Tissue Gene Tests
United States
67
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Exudative vitreoretinopathy NGS panel

HNL Genomics Connective Tissue Gene Tests
United States
67
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Exudative vitreoretinopathy Deletion / Duplication panel

HNL Genomics Connective Tissue Gene Tests
United States
67
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Exudative vitreoretinopathy 5, 613310, Autosomal dominant; EVR5 (Familial exudative vitreoretinopathy) (TSPAN12 gene) (Sequence Analysis-All Coding Exons) (Postnatal)

Intergen Intergen Genetics and Rare Diseases Diagnosis Center
Turkey
11
  • C Sequence analysis of the entire coding region

Invitae Inherited Retinal Disorders Panel

Labcorp Genetics (formerly Invitae) LabCorp
United States
486293
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Vitreoretinopathy and Wagner syndrome

Amplexa Genetics Amplexa Genetics A/S
Denmark
16
  • S Mutation scanning of the entire coding region

Familial Exudative Vitreoretinopathy and Wagner Syndrome

Amplexa Genetics Amplexa Genetics A/S
Denmark
28
  • S Mutation scanning of the entire coding region

MVL Vision Panel

Molecular Vision Laboratory
United States
342268
  • C Sequence analysis of the entire coding region

Vitreoretinopathy NGS panel

HNL Genomics Connective Tissue Gene Tests
United States
2319
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Vitreoretinopathy Deletion / Duplication panel

HNL Genomics Connective Tissue Gene Tests
United States
2319
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Vitreoretinopathy Comprehensive panel

HNL Genomics Connective Tissue Gene Tests
United States
2319
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Exudative vitreoretinopathy NGS panel

HNL Genomics Connective Tissue Gene Tests
United States
67
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Exudative vitreoretinopathy Comprehensive panel

HNL Genomics Connective Tissue Gene Tests
United States
67
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Exudative vitreoretinopathy Deletion / Duplication panel

HNL Genomics Connective Tissue Gene Tests
United States
67
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Comprehensive Vitreoretinopathy Panel

PreventionGenetics, part of Exact Sciences
United States
2621
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Results: 1 to 20 of 58

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.